The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Binding interaction of quercetin-3-β-galactoside and its synthetic derivatives with SARS-CoV 3CLpro: Structure–activity relationship studies reveal salient pharmacophore features
Open accessAbstract
Graphical abstract A new class of compounds that have been designed and synthesized based on a natural product, quercetin-3-β-galactoside, has been discovered to be effective inhibitors of SARS coronavirus 3CL protease (SARS-CoV 3CLpro), which could be developed as drug leads for SARS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules
Cornell, W. D., Cieplak, P., Bayly, C. I., Gould, I. R., Merz, K. M., Ferguson, D. M., Spellmeyer, D. C., Fox, T., Caldwell, J. W., & Kollman, P. A. (1995) · Journal of the American Chemical Society · doi:10.1021/ja00124a002 · Cited by 13,103
Iterative partial equalization of orbital electronegativity—a rapid access to atomic charges
Gasteiger, J., & Marsili, M. (1980) · Tetrahedron · doi:10.1016/0040-4020(80)80168-2 · Cited by 4,157
A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong
Lee, N., Hui, D., Wu, A., Chan, P., Cameron, P., Joynt, G. M., Ahuja, A., Yung, M. Y., Leung, C. B., To, K. F., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030685 · Cited by 2,628
Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Rota, P. A., Oberste, M. S., Monroe, S. S., Nix, W. A., Campagnoli, R., Icenogle, J. P., Peñaranda, S., Bankamp, B., Maher, K., Chen, M.-H., et al. (2003) · Science · doi:10.1126/science.1085952 · Cited by 2,474
The Genome Sequence of the SARS-Associated Coronavirus
Marra, M. A., Jones, S. J. M., Astell, C. R., Holt, R. A., Brooks-Wilson, A., Butterfield, Y. S. N., Khattra, J., Asano, J. K., Barber, S. A., Chan, S. Y., et al. (2003) · Science · doi:10.1126/science.1085953 · Cited by 2,026
Coronavirus Main Proteinase (3CL pro ) Structure: Basis for Design of Anti-SARS Drugs
Anand, K., Ziebuhr, J., Wadhwani, P., Mesters, J. R., & Hilgenfeld, R. (2003) · Science · doi:10.1126/science.1085658 · Cited by 1,728
Snijder, E. J., Bredenbeek, P. J., Dobbe, J. C., Thiel, V., Ziebuhr, J., Poon, L. L. M., Guan, Y., Rozanov, M., Spaan, W. J. M., & Gorbalenya, A. E. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00865-9 · Cited by 1,198
DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases
Ewing, T. J. A., Makino, S., Skillman, A. G., & Kuntz, I. D. (2001) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1011115820450 · Cited by 1,187
Identification of Severe Acute Respiratory Syndrome in Canada
Poutanen, S. M., Low, D. E., Henry, B., Finkelstein, S., Rose, D., Green, K., Tellier, R., Draker, R., Adachi, D., Ayers, M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030634 · Cited by 1,132
A Cluster of Cases of Severe Acute Respiratory Syndrome in Hong Kong
Tsang, K. W., Ho, P. L., Ooi, G. C., Yee, W. K., Wang, T., Chan-Yeung, M., Lam, W. K., Seto, W. H., Yam, L. Y., Cheung, T. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030666 · Cited by 1,017
Yang, H., Yang, M., Ding, Y., Liu, Y., Lou, Z., Zhou, Z., Sun, L., Mo, L., Ye, S., Pang, H., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1835675100 · Cited by 990
Koch's postulates fulfilled for SARS virus
Fouchier, R. A. M., Kuiken, T., Schutten, M., van Amerongen, G., van Doornum, G. J. J., van den Hoogen, B. G., Peiris, M., Lim, W., Stöhr, K., & Osterhaus, A. D. M. E. (2003) · Nature · doi:10.1038/423240a · Cited by 789
Hayek, T., Fuhrman, B., Vaya, J., Rosenblat, M., Belinky, P., Coleman, R., Elis, A., & Aviram, M. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.11.2744 · Cited by 552
Lin, C.-W., Tsai, F.-J., Tsai, C.-H., Lai, C.-C., Wan, L., Ho, T.-Y., Hsieh, C.-C., & Chao, P.-D. L. (2005) · Antiviral Research · doi:10.1016/j.antiviral.2005.07.002 · Cited by 545
Small molecules targeting severe acute respiratory syndrome human coronavirus
Wu, C.-Y., Jan, J.-T., Ma, S.-H., Kuo, C.-J., Juan, H.-F., Cheng, Y.-S. E., Hsu, H.-H., Huang, H.-C., Wu, D., Brik, A., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403596101 · Cited by 521
Small Molecules Blocking the Entry of Severe Acute Respiratory Syndrome Coronavirus into Host Cells
Yi, L., Li, Z., Yuan, K., Qu, X., Chen, J., Wang, G., Zhang, H., Luo, H., Zhu, L., Jiang, P., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.20.11334-11339.2004 · Cited by 485
Self-citationFan, K., Wei, P., Feng, Q., Chen, S., Huang, C., Ma, L., Lai, B., Pei, J., Liu, Y., Chen, J., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310875200 · Cited by 327
Mouria, M., Gukovskaya, A. S., Jung, Y., Buechler, P., Hines, O. J., Reber, H. A., & Pandol, S. J. (2002) · International Journal of Cancer · doi:10.1002/ijc.10202 · Cited by 274
Mechanism of the Maturation Process of SARS-CoV 3CL Protease
Hsu, M.-F., Kuo, C.-J., Chang, K.-T., Chang, H.-C., Chou, C.-C., Ko, T.-P., Shr, H.-L., Chang, G.-G., Wang, A. H.-J., & Liang, P.-H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502577200 · Cited by 262
Inhibition of SARS‐CoV 3C‐like Protease Activity by Theaflavin‐3,3′‐digallate (TF3)
Chen, C.-N., Lin, C. P. C., Huang, K.-K., Chen, W.-C., Hsieh, H.-P., Liang, P.-H., & Hsu, J. T.-A. (2005) · Evidence-Based Complementary and Alternative Medicine · doi:10.1093/ecam/neh081 · Cited by 239
Identification of Novel Inhibitors of the SARS Coronavirus Main Protease 3CLpro
Bacha, U., Barrila, J., Velazquez-Campoy, A., Leavitt, S. A., & Freire, E. (2004) · Biochemistry · doi:10.1021/bi0361766 · Cited by 218
3C-like Proteinase from SARS Coronavirus Catalyzes Substrate Hydrolysis by a General Base Mechanism
Huang, C., Wei, P., Fan, K., Liu, Y., & Lai, L. (2004) · Biochemistry · doi:10.1021/bi036022q · Cited by 215
High-Throughput Screening Identifies Inhibitors of the SARS Coronavirus Main Proteinase
Blanchard, J. E., Elowe, N. H., Huitema, C., Fortin, P. D., Cechetto, J. D., Eltis, L. D., & Brown, E. D. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.08.011 · Cited by 206
Chen, L., Gui, C., Luo, X., Yang, Q., Günther, S., Scandella, E., Drosten, C., Bai, D., He, X., Ludewig, B., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.11.7095-7103.2005 · Cited by 191
Self-citationShi, J., Wei, Z., & Song, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311744200 · Cited by 190
Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate
Kuo, C.-J., Chi, Y.-H., Hsu, J. T.-A., & Liang, P.-H. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.098 · Cited by 158
Effects of chronic quercetin treatment in experimental renovascular hypertension
Garc�a-Saura, M. F., Galisteo, M., Villar, I. C., Bermejo, A., Zarzuelo, A., Vargas, F., & Duarte, J. (2005) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-4503-0 · Cited by 120
Severe acute respiratory syndrome: identification of the etiological agent
Drosten, C., Preiser, W., Günther, S., SCHMITZ, H. E., & Doerr, H. W. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00133-3 · Cited by 113
Chen, D., Chen, L., Tan, J., Chen, J., Du, L., Sun, T., Shen, J., Chen, K., Jiang, H., & Shen, X. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408211200 · Cited by 106
Self-citationDiscovery of Potent Anilide Inhibitors against the Severe Acute Respiratory Syndrome 3CL Protease
Shie, J., Fang, J., Kuo, C., Kuo, T., Liang, P., Huang, H., Yang, W., Lin, C., Chen, J.-L., Wu, Y.-T., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050184y · Cited by 102
Evaluation of metal‐conjugated compounds as inhibitors of 3CL protease of SARS‐CoV
Hsu, J. T.-A., Kuo, C., Hsieh, H., Wang, Y.-C., Huang, K., Lin, C. P. C., Huang, P.-F., Chen, X., & Liang, P. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.08.015 · Cited by 94
A 3D model of SARS_CoV 3CL proteinase and its inhibitors design by virtual screening.
Xiong, B., Gui, C. S., Xu, X.-Y., Luo, C., Chen, J., Luo, H., Chen, L. L., Li, G. W., Sun, T., Yu, C. Y., et al. (2003) · PubMed · Cited by 73
Self-citationVirtual Screening of Novel Noncovalent Inhibitors for SARS-CoV 3C-like Proteinase
Liu, Z., Huang, C., Fan, K., Wei, P., Chen, H., Liu, S., Pei, J., Shi, L., Li, B., Yang, K., et al. (2004) · Journal of Chemical Information and Modeling · doi:10.1021/ci049809b · Cited by 65
Kao, R. Y. T., To, A. P. C., Ng, L. W. Y., et al. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.09.026 · Cited by 57
Screening of drugs by FRET analysis identifies inhibitors of SARS-CoV 3CL protease
Liu, Y.-C., Huang, V., Chao, T., Hsiao, C., Lin, A., Chang, M., & Chow, L. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.095 · Cited by 48
Sun, H., Luo, H., Yu, C., Sun, T., Chen, J., Peng, S., Qin, J., Shen, J., Yang, Y., Xie, Y., et al. (2003) · Protein Expression and Purification · doi:10.1016/j.pep.2003.08.016 · Cited by 28
Self-citationSingh, D., Chander, V., & Chopra, K. (2004) · Drug and Chemical Toxicology · doi:10.1081/dct-120030729 · Cited by 27
“Teaching old drugs to kill new bugs”: structure-based discovery of anti-SARS drugs
Rajnarayanan, R. V., Dakshanamurthy, S., & Pattabiraman, N. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.06.155 · Cited by 27
(1998) · doi:10.1002/(sici)1096-987x(19981115)19:14<1639::aid-jcc10>3.0.co;2-b
Cited by
Coronavirus disease 2019 (COVID-19): current status and future perspectives
Li, H., Liu, S.-M., Yu, X.-H., Tang, S.-L., & Tang, C.-K. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105951 · Cited by 1,156
Colunga Biancatelli, R. M. L., Berrill, M., Catravas, J. D., & Marik, P. E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01451 · Cited by 512
Zhang, D.-H., Wu, K.-L., Zhang, X., Deng, S.-Q., & Peng, B. (2020) · Journal of Integrative Medicine · doi:10.1016/j.joim.2020.02.005 · Cited by 482
Flieger, J., Flieger, W., Baj, J., & Maciejewski, R. (2021) · Materials · doi:10.3390/ma14154135 · Cited by 441
Quercetin and its derivates as antiviral potentials: A comprehensive review
Di Petrillo, A., Orrù, G., Fais, A., & Fantini, M. C. (2022) · Phytotherapy Research · doi:10.1002/ptr.7309 · Cited by 431
Metadata
- Authors
- Chen, L., Li, J., Luo, C., Liu, H., Xu, W., Chen, G., Liew, O. W., Zhu, W., Puah, C. M., Shen, X., & Jiang, H.
- Venue
- Bioorganic & Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2006-12
- Volume
- 14
- Issue
- 24
- Pages
- 8295-8306
- ISSN
- 0968-0896 (ISSN-L)
- OpenAlex
- W2007679990
- Cited by
- 265
- References
- 39
- FWCI
- 2.68
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.